These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8516039)

  • 1. Transfusional hemosiderosis in sickle cell anemia: another cause of an echogenic pancreas.
    Flyer MA; Haller JO; Sundaram R
    Pediatr Radiol; 1993; 23(2):140-2. PubMed ID: 8516039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusional hemosiderosis and combined chelation therapy in sickle thalassemia.
    Tsironi M; Polonifi K; Deftereos S; Farmakis D; Andriopoulos P; Moyssakis I; Aessopos A
    Eur J Haematol; 2005 Oct; 75(4):355-8. PubMed ID: 16146544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron burden in sickle cell anemia.
    O'Brien RT
    J Pediatr; 1978 Apr; 92(4):579-82. PubMed ID: 633016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR marrow signs of iron overload in transfusion-dependent patients with sickle cell disease.
    Levin TL; Sheth SS; Hurlet A; Comerci SC; Ruzal-Shapiro C; Piomelli S; Berdon WE
    Pediatr Radiol; 1995; 25(8):614-9. PubMed ID: 8570314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR evaluation of liver iron overload.
    Hernandez RJ; Sarnaik SA; Lande I; Aisen AM; Glazer GM; Chenevert T; Martel W
    J Comput Assist Tomogr; 1988; 12(1):91-4. PubMed ID: 3335677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation.
    Stanley HM; Friedman DF; Webb J; Kwiatkowski JL
    Pediatr Blood Cancer; 2016 Aug; 63(8):1414-8. PubMed ID: 27100139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial.
    Vichinsky E; Pakbaz Z; Onyekwere O; Porter J; Swerdlow P; Coates T; Lane P; Files B; Mueller BU; Coïc L; Forni GL; Fischer R; Marks P; Rofail D; Abetz L; Baladi JF
    Acta Haematol; 2008; 119(3):133-41. PubMed ID: 18408362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between Heart, Liver and Pancreas Hemosiderosis Measured by MRI T2* among Thalassemia Major Patients from Iran.
    Azarkeivan A; Hashemieh M; Shirkavand A; Sheibani K
    Arch Iran Med; 2016 Feb; 19(2):96-100. PubMed ID: 26838079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial.
    Wood JC; Cohen AR; Pressel SL; Aygun B; Imran H; Luchtman-Jones L; Thompson AA; Fuh B; Schultz WH; Davis BR; Ware RE;
    Br J Haematol; 2016 Jan; 172(1):122-30. PubMed ID: 26523836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging of transfusional hemosiderosis complicating thalassemia major.
    Brasch RC; Wesbey GE; Gooding CA; Koerper MA
    Radiology; 1984 Mar; 150(3):767-71. PubMed ID: 6695078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron overload? In sickle cell disease?
    Day S; Dancy R; Kelly K; Wang W
    MCN Am J Matern Child Nurs; 1993; 18(6):330-5. PubMed ID: 8295522
    [No Abstract]   [Full Text] [Related]  

  • 12. Retrospective epidemiological study of Latin American patients with transfusional hemosiderosis: the first Latin American epidemiological study in iron overload--the RELATH study.
    Lobo C; Angulo IL; Aparicio LR; Drelichman GI; Zanichelli MA; Cancado R;
    Hematology; 2011 Sep; 16(5):265-73. PubMed ID: 21902889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
    Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
    Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron-Containing Abdominal Pathologies: Exploiting Magnetic Susceptibility Artifact on Dual-Echo Gradient-Echo Magnetic Resonance Imaging.
    Thomas AJ; Morani AC; Liu PS; Weadock WJ; Hussain HK; Elsayes KM
    J Comput Assist Tomogr; 2019; 43(2):165-175. PubMed ID: 30371618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detoxification in hemosiderosis.
    Simon P
    Blood Purif; 1985; 3(1-3):75-88. PubMed ID: 3913449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorlike, iron-sparing foci of splenic hemosiderosis in a child with sickle cell anemia.
    Donkol RH; Monib S; Eltounsi I
    J Ultrasound Med; 2006 Dec; 25(12):1607-9. PubMed ID: 17121959
    [No Abstract]   [Full Text] [Related]  

  • 17. Transfusion therapy: a coming-of-age treatment for patients with sickle cell disease.
    Reed W; Vichinsky EP
    J Pediatr Hematol Oncol; 2001 May; 23(4):197-202. PubMed ID: 11846294
    [No Abstract]   [Full Text] [Related]  

  • 18. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
    Kwiatkowski JL; Cohen AR; Garro J; Alvarez O; Nagasubramanian R; Sarnaik S; Thompson A; Woods GM; Schultz W; Mortier N; Lane P; Mueller B; Yovetich N; Ware RE;
    Am J Hematol; 2012 Feb; 87(2):221-3. PubMed ID: 22120913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of post-transfusion iron overload by deferoxamine].
    de Montalembert M; Llados A; Hannedouche T; Girot R
    Arch Fr Pediatr; 1989 Feb; 46(2):99-105. PubMed ID: 2735804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels.
    Karam LB; Disco D; Jackson SM; Lewin D; McKie V; Baker RD; Baker SS; Laver JH; Nietert PJ; Abboud MR
    Pediatr Blood Cancer; 2008 Jan; 50(1):62-5. PubMed ID: 17457853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.